Patient interview comments and HBV/HDV status before LT for the HBIg group
| Patient no. | Interview comments | HBV/HDV status before LT | Liver function at test (ALT/AST [IU/mL]) |
|---|---|---|---|
| 53 | NA regimen noncompliance in 2021 | HBV DNA, target not detected HDV RNA, target not detected |
141/40 |
| 16 | NA regimen noncompliance in 2020 | No information available | 53/48 |
| 84 | NA regimen noncompliance since LT | HBV DNA, target not detected HDV RNA, target not detected |
19.5/28.3 |
| 26 | NA regimen noncompliance in 2020 | HBV DNA, 454,000 IU/mL HDV RNA, target not detected |
66/45 |
HBV, hepatitis B virus; HDV, hepatitis D virus; LT, liver transplant; HBIg, hepatitis B immunoglobulin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; NA, nucleos(t)ide analogue.
a)Range, 0–40 IU/mL.